These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30213375)

  • 1. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
    Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
    J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
    Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of KIT receptor in feline cutaneous mast cell tumors.
    Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
    Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
    Sabattini S; Bettini G
    Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours.
    Sabattini S; Barzon G; Giantin M; Lopparelli RM; Dacasto M; Prata D; Bettini G
    Vet Comp Oncol; 2017 Sep; 15(3):1051-1061. PubMed ID: 27278268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines.
    Takeuchi Y; Fujino Y; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):208-16. PubMed ID: 20591500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell factor contributes to tumorigenesis of mast cells via an autocrine/paracrine mechanism.
    Amagai Y; Tanaka A; Matsuda A; Jung K; Ohmori K; Matsuda H
    J Leukoc Biol; 2013 Feb; 93(2):245-50. PubMed ID: 23125456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of the c-KIT c.1430G>T mutation by mutant-specific polymerase chain reaction in feline mast cell tumours.
    Takanosu M; Sato M; Kagawa Y
    Vet Comp Oncol; 2014 Jun; 12(2):138-42. PubMed ID: 22891713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Minichromosome Maintenance Protein 7 and c-KIT as Prognostic Markers in Feline Cutaneous Mast Cell Tumours.
    Dobromylskyj MJ; Rasotto R; Melville K; Smith KC; Berlato D
    J Comp Pathol; 2015 Nov; 153(4):244-50. PubMed ID: 26385324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
    Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
    Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine/Paracrine Loop Between SCF
    Annese T; Tamma R; Bozza M; Zito A; Ribatti D
    Front Immunol; 2022; 13():794974. PubMed ID: 35140718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
    Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
    Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
    Isotani M; Yamada O; Lachowicz JL; Tamura K; Yagihara H; Fujino Y; Ono K; Washizu T; Bonkobara M
    Br J Haematol; 2010 Jan; 148(1):144-53. PubMed ID: 19804453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
    Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
    Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIN3 is a negative regulator of mast cell responses to SCF.
    Janson C; Kasahara N; Prendergast GC; Colicelli J
    PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
    Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
    Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.
    Krasagakis K; Kruger-Krasagakis S; Eberle J; Tsatsakis A; Tosca AD; Stathopoulos EN
    Dermatology; 2009; 218(1):37-43. PubMed ID: 19001805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of stem cell factor in canine mast cell tumors.
    Amagai Y; Tanaka A; Jung K; Matsuda A; Oida K; Nishikawa S; Jang H; Ishizaka S; Matsuda H
    Res Vet Sci; 2014 Feb; 96(1):124-6. PubMed ID: 24269079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
    Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
    BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
    Meyer A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.